GlassScriptPhysician profile
Weera Chainakul
NPI 1932142866
$4,514.47
in general payments reported to CMS, 2019-2025
37 companies · $714 in 2025
The $714 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $138 · 2021: $693 · 2022: $554 · 2023: $1,091 · 2024: $768 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,572.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $887.37 | 2019-2025 | Collagenase Santyl, Oasis, Versajet |
| Stryker Corporation | $558.21 | 2021 | |
| Intuitive Surgical, INC. | $394.51 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $273.32 | 2020-2024 | Phasix Mesh |
| Avita Medical Americas, LLC | $225.87 | 2024-2025 | Cohealyx, Permeaderm, Recell |
| Kerecis Limited | $222.33 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kci USA, INC. | $222.09 | 2019-2023 | Prevena, V.A.C. Veraflo, V.A.C. Dermatac |
| Baxter Healthcare | $212.47 | 2019-2025 | Perclot, Tisseel, Artiss |
| Organogenesis INC. | $201.44 | 2019-2024 | Puraply, Affinity |
| Polynovo North America LLC | $190.17 | 2022-2025 | Novosorb Btm |
| Vericel Corporation | $176.77 | 2024 | Nexobrid |
| Acera Surgical, INC. | $153.13 | 2024-2025 | Restrata Wound Matrix |
| Allergan, INC. | $107.10 | 2019-2020 | |
| Tei Biosciences INC | $82.85 | 2019 | |
| Aroa Biosurgery Incorporated | $52.80 | 2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $44.64 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $44.39 | 2023 | Andexxa |
| Access Pro Medical, LLC | $41.54 | 2022-2025 | Matriderm |
| Shire North American Group INC | $33.39 | 2019 | |
| Ethicon US, LLC | $29.86 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $28.54 | 2024 | |
| 3m Company | $28.04 | 2019 | |
| Conmed Corporation | $28.00 | 2022 | |
| Urgo Medical North America, LLC | $25.70 | 2025 | Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| W. L. Gore & Associates, INC. | $25.31 | 2022 | |
| Medtronic, INC. | $23.96 | 2025 | Transorb |
| Kowa Pharmaceuticals America, INC. | $23.30 | 2022 | |
| Btg International INC. | $22.66 | 2025 | Aurlumyn |
| Solventum Corporation | $21.99 | 2024 | Activ.A.C. |
| Hollister Incorporated | $20.98 | 2025 | Adapt Ceraring |
| Integra Lifesciences Corporation | $20.88 | 2020 | |
| Osiris Therapeutics INC. | $19.63 | 2019 | |
| Pfizer INC. | $17.28 | 2019 | |
| Cook Medical LLC | $15.88 | 2019 | |
| Biocomposites INC | $14.66 | 2025 | Stimulan |
| Reprise Biomedical, INC. | $12.61 | 2025 | Miro3d |
| Roche Diagnostics Corporation | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weera Chainakul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.